Primary Graft Dysfunction: Clinical Trials

1 trial for Primary Graft Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Primary Graft Dysfunction: new trials by email Literature Review of Primary Graft Dysfunction trials Research Report on Primary Graft Dysfunction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
Maraviroc, Placebo - Primary Graft Dysfunction, Lung Transplantation
Phase 2RecruitingUniversity of California, San Francisco1202025-12-072026-01-20

Narrower conditions

Acute Lung Injury (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Lung Diseases (1)  ·  Lung Injury (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Reperfusion Injury (1)  ·  Respiratory Tract Diseases (1)  ·  Vascular Diseases (1)

Interventions

Maraviroc (1)

Sponsors

University of California, San Francisco (1)

Countries

United States (1)

Top investigators

Daniel Calabrese, MD (1)